Breed s Hill Capital LLC Acquires 428 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

by · The Cerbat Gem

Breed s Hill Capital LLC boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 77.7% in the 4th quarter, Holdings Channel.com reports. The firm owned 979 shares of the healthcare conglomerate’s stock after purchasing an additional 428 shares during the quarter. Breed s Hill Capital LLC’s holdings in UnitedHealth Group were worth $495,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the business. NewSquare Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group during the fourth quarter worth $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth $28,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth $30,000. Finally, Aster Capital Management DIFC Ltd acquired a new position in shares of UnitedHealth Group during the fourth quarter worth $30,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $296.45 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a 50-day moving average of $456.57 and a 200-day moving average of $506.94. The company has a market cap of $268.92 billion, a PE ratio of 19.13, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the previous year, the business posted $6.91 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 2.83%. UnitedHealth Group’s payout ratio is 35.18%.

Insider Activity at UnitedHealth Group

In other news, CEO Stephen J. Hemsley bought 86,700 shares of the company’s stock in a transaction on Friday, May 16th. The shares were purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. This represents a 14.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of the company’s stock in a transaction on Wednesday, May 14th. The shares were purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders have acquired 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on UNH. Bank of America downgraded shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Raymond James downgraded UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. Mizuho decreased their price objective on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. TD Securities restated a “hold” rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a report on Monday. Finally, TD Cowen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective for the company. in a report on Monday. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $441.87.

Read Our Latest Analysis on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).